Investigating the role of specific proteins in lung cancer progression
Rac guanine nucleotide exchange factors in lung cancer
['FUNDING_R01'] · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · NIH-11147003
This study is looking at how certain proteins might help lung cancer grow and spread, especially in patients with a specific gene mutation, to find new ways to treat the disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (CORAL GABLES, UNITED STATES) |
| Trial ID | NIH-11147003 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how certain proteins, known as Rac guanine nucleotide exchange factors (Rac-GEFs), contribute to the progression of lung adenocarcinoma, a common type of lung cancer. By using advanced techniques like CRISPR, researchers will create specific cell lines to study the effects of these proteins on cancer cell movement and invasion. The goal is to identify which Rac-GEFs are crucial for the aggressive behavior of lung cancer cells, particularly those with mutations in the KRAS gene. This could lead to new insights into potential therapeutic targets for lung cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with lung adenocarcinoma, particularly those with KRAS mutations.
Not a fit: Patients with lung cancer types that do not involve KRAS mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies that improve outcomes for lung cancer patients.
How similar studies have performed: Other research has shown success in targeting similar pathways in cancer treatment, indicating potential for this approach.
Where this research is happening
CORAL GABLES, UNITED STATES
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE — CORAL GABLES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KAZANIETZ, MARCELO G. — UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- Study coordinator: KAZANIETZ, MARCELO G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.